Core Viewpoint - China Tongfu (01763) has announced the launch of a new isotope separation technology called "Adsorption Catcher," based on the fourth-generation "MOF" materials, which aims to enhance high-end nuclear medicine and controllable nuclear fusion sectors, opening new industrial development prospects [1] Group 1: Technology Innovation - The "Adsorption Catcher" technology innovatively incorporates fourth-generation "MOF" materials, which are the focus of the 2025 Nobel Prize in Chemistry, breaking the traditional framework of isotope separation technology [1] - This technology enables "customized design" of separation materials at the molecular level, showcasing significant advantages in "high purity, high efficiency, low cost, and low energy consumption" [1] Group 2: Application and Impact - The technology has a wide range of applications, covering key areas such as nuclear medicine, nuclear fusion, heavy water reactors, and biomedical research, which are crucial to the national economy [1] - It will provide core technological support for building a "self-controllable, safe, and stable" isotope supply chain in China, helping to reduce reliance on imported high-end isotopes [1]

Core Viewpoint - China Zhongfu (01763) has announced the launch of a new isotope separation technology called "Adsorption Catcher," based on the fourth-generation "MOF" materials, which aims to enhance high-end nuclear medicine and controllable nuclear fusion sectors, opening new industrial development prospects [1] Group 1: Technology Innovation - The "Adsorption Catcher" technology innovatively incorporates fourth-generation "MOF" materials, which are the focus of the 2025 Nobel Prize in Chemistry, breaking the traditional framework of isotope separation technology [1] - This technology enables "customized design" of separation materials at the molecular level, showcasing significant advantages in "high purity, high efficiency, low cost, and low energy consumption" [1] Group 2: Application and Impact - The technology has a wide range of applications, covering key areas such as nuclear medicine, nuclear fusion, heavy water reactors, and biomedical research, which are crucial to the national economy [1] - It will provide core technological support for building a "self-controllable, safe, and stable" isotope supply chain in China, helping to reduce dependence on imported high-end isotopes [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 CHINA ISOTOPE & RADIATION CORPORATION 中國同輻股份有限公司 本公告乃中國同輻股份有限公司（「中國同輻」或「本公司」）自願發出以使股東及潛 在投資者知悉本公司之最新業務進展。 本公司董事會欣然宣佈，近日，中國同輻附屬公司成都中核高通同位素股份有限 公司「中核高通」正式發佈了基於第四代「MOF」材料的同位素分離新技術——「吸 附捕手」，為高端核醫療和可控核聚變領域注入新動能，開闢了產業化發展新前 景。 「吸附捕手」技術創新性引入了2025年諾貝爾化學獎聚焦的第四代「MOF」材料， 突破傳統同位素分離技術的固有框架，在分子尺度上實現分離材料的「定制化設 計」。「吸附捕手」技術展現出「高純度、高效率、低成本、低能耗」的顯著優勢， 應用面廣泛，覆蓋核醫療、核聚變、重水堆、生物醫學研究等多個面向國民經濟 主戰場的關鍵領域，將為我國構建「自主可控、安全穩定」的同位素供應鏈提供核 ...